|
DK3184526T3
(en)
|
2005-12-13 |
2019-01-14 |
Incyte Holdings Corp |
PYRROLO [2,3-D] PYRIMIDINE DERIVATIVES AS A JANUS-KINASE INHIBITOR
|
|
EP2740731B1
(en)
|
2007-06-13 |
2016-03-23 |
Incyte Holdings Corporation |
Crystalline salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
|
|
JP5769199B2
(ja)
|
2008-10-31 |
2015-08-26 |
ジェネンテック， インコーポレイテッド |
ピラゾロピリミジンｊａｋ阻害剤化合物と方法
|
|
WO2010135621A1
(en)
|
2009-05-22 |
2010-11-25 |
Incyte Corporation |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
|
|
PE20120493A1
(es)
|
2009-06-29 |
2012-05-20 |
Incyte Corp |
Pirimidinonas como inhibidores de pi3k
|
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
|
SMT201800137T1
(it)
|
2010-03-10 |
2018-07-17 |
Incyte Holdings Corp |
Derivati di piperidin-4-il azetidina come inibitori di jak1
|
|
AR081823A1
(es)
|
2010-04-14 |
2012-10-24 |
Incyte Corp |
DERIVADOS FUSIONADOS COMO INHIBIDORES DE PI3Kd
|
|
PH12012502296B1
(en)
|
2010-05-21 |
2017-10-06 |
Incyte Holdings Corp |
Topical formulation for a jak inhibitor
|
|
WO2011163195A1
(en)
|
2010-06-21 |
2011-12-29 |
Incyte Corporation |
Fused pyrrole derivatives as pi3k inhibitors
|
|
JP2013534233A
(ja)
*
|
2010-08-20 |
2013-09-02 |
セルゾーム リミティッド |
選択的ｊａｋ阻害剤としてのヘテロシクリルピラゾロピリミジン類似体
|
|
BR112013006016A2
(pt)
|
2010-09-15 |
2016-06-07 |
Hoffmann La Roche |
compostos de azabenzotiazol, composições e métodos de uso
|
|
SG190839A1
(en)
|
2010-11-19 |
2013-07-31 |
Incyte Corp |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
KR20140009259A
(ko)
|
2010-11-19 |
2014-01-22 |
에프. 호프만-라 로슈 아게 |
피라졸로피리딘 및 tyk2 억제제로서 이의 용도
|
|
ES2764848T3
(es)
|
2010-12-20 |
2020-06-04 |
Incyte Holdings Corp |
N-(1-(fenilo sustituido)etilo)-9H-purina-6-aminas como inhibidores de PI3K
|
|
WO2012125629A1
(en)
|
2011-03-14 |
2012-09-20 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
|
|
WO2012135009A1
(en)
|
2011-03-25 |
2012-10-04 |
Incyte Corporation |
Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
|
|
WO2012143320A1
(en)
|
2011-04-18 |
2012-10-26 |
Cellzome Limited |
(7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors
|
|
WO2012177606A1
(en)
|
2011-06-20 |
2012-12-27 |
Incyte Corporation |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
|
US20140179664A1
(en)
|
2011-07-28 |
2014-06-26 |
Cellzome Limited |
Heterocyclyl Pyrimidine Analogues As JAK Inhibitors
|
|
WO2013017480A1
(en)
|
2011-07-29 |
2013-02-07 |
Cellzome Limited |
Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
|
|
WO2013017479A1
(en)
|
2011-07-29 |
2013-02-07 |
Cellzome Limited |
Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
|
|
KR20230038593A
(ko)
|
2011-09-02 |
2023-03-20 |
인사이트 홀딩스 코포레이션 |
Ｐｉ３ｋ 억제제로서 헤테로시클릴아민
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
JP2014531449A
(ja)
*
|
2011-09-20 |
2014-11-27 |
セルゾーム リミティッド |
キナーゼ阻害剤としてのピラゾロ［４，３―ｃ］ピリジン誘導体
|
|
US20150005281A1
(en)
|
2011-12-23 |
2015-01-01 |
Cellzome Limited |
Pyrimidine-2,4-diamine derivatives as kinase inhibitors
|
|
CN103193600B
(zh)
*
|
2012-01-07 |
2016-04-06 |
浙江九洲药物科技有限公司 |
卡巴拉汀中间体的制备方法
|
|
CN104066734B
(zh)
*
|
2012-01-28 |
2017-03-29 |
默克专利股份公司 |
三唑并[4,5‑d]嘧啶衍生物
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
US9296725B2
(en)
|
2012-05-24 |
2016-03-29 |
Cellzome Limited |
Heterocyclyl pyrimidine analogues as TYK2 inhibitors
|
|
PE20151157A1
(es)
|
2012-11-15 |
2015-08-19 |
Incyte Corp |
Formas de dosificacion de ruxolitinib de liberacion sostenida
|
|
MA38287B1
(fr)
|
2013-01-23 |
2018-08-31 |
Astrazeneca Ab |
Nouveaux dérivés aminopyrazine pour le traitement ou la prévention du cancer
|
|
LT3489239T
(lt)
|
2013-03-06 |
2022-03-10 |
Incyte Holdings Corporation |
Jak inhibitoriaus gamybos būdai ir tarpiniai junginiai
|
|
UA120499C2
(uk)
|
2013-08-07 |
2019-12-26 |
Інсайт Корпорейшн |
Лікування захворювань із застосуванням лікарських форм з уповільненим вивільненням для інгібітора jak1
|
|
WO2015038417A1
(en)
*
|
2013-09-10 |
2015-03-19 |
Asana Biosciences, Llc |
Compounds for regulating fak and/or src pathways
|
|
US9102655B2
(en)
|
2013-10-17 |
2015-08-11 |
Dow Agrosciences Llc |
Processes for the preparation of pesticidal compounds
|
|
US9346815B2
(en)
|
2014-05-23 |
2016-05-24 |
Genentech, Inc. |
5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof
|
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
|
TW201613916A
(en)
|
2014-06-03 |
2016-04-16 |
Gilead Sciences Inc |
TANK-binding kinase inhibitor compounds
|
|
WO2015191677A1
(en)
|
2014-06-11 |
2015-12-17 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
|
|
KR101949624B1
(ko)
|
2014-09-26 |
2019-02-18 |
길리애드 사이언시즈, 인코포레이티드 |
Tank-결합 키나제 억제제 화합물로서 유용한 아미노트리아진 유도체
|
|
PH12017501538B1
(en)
|
2015-02-27 |
2024-02-14 |
Incyte Holdings Corp |
Salts of p13k inhibitor and processes for their preparation
|
|
AU2016251253B2
(en)
*
|
2015-04-24 |
2020-07-09 |
Guangzhou Maxinovel Pharmaceuticals Co., Ltd |
Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof
|
|
US9988401B2
(en)
|
2015-05-11 |
2018-06-05 |
Incyte Corporation |
Crystalline forms of a PI3K inhibitor
|
|
US9732097B2
(en)
|
2015-05-11 |
2017-08-15 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
|
WO2017106556A1
(en)
|
2015-12-17 |
2017-06-22 |
Gilead Sciences, Inc. |
Tank-binding kinase inhibitor compounds
|
|
JP6985388B2
(ja)
*
|
2016-07-29 |
2021-12-22 |
ラプト・セラピューティクス・インコーポレイテッド |
ケモカイン受容体調節剤及びそれの使用
|
|
JP2020503336A
(ja)
|
2016-12-29 |
2020-01-30 |
ダウ アグロサイエンシィズ エルエルシー |
殺有害生物化合物の調製方法
|
|
US10233155B2
(en)
*
|
2016-12-29 |
2019-03-19 |
Dow Agrosciences Llc |
Processes for the preparation of pesticide compounds
|
|
PL233595B1
(pl)
*
|
2017-05-12 |
2019-11-29 |
Celon Pharma Spolka Akcyjna |
Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK
|
|
BR112019024322A2
(pt)
|
2017-05-22 |
2020-06-16 |
F. Hoffmann-La Roche Ag |
Compostos e composições terapêuticos e métodos de uso dos mesmos
|
|
SG11202005264PA
(en)
*
|
2017-12-05 |
2020-07-29 |
Oscotec Inc |
Pyrrolo(pyrazolo)pyrimidine derivative as lrrk2 inhibitor
|
|
WO2019113487A1
(en)
|
2017-12-08 |
2019-06-13 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
IL276302B2
(en)
|
2018-01-30 |
2023-11-01 |
Incyte Corp |
Procedures for preparing [1-(3-fluoro-2-(trifluoromethyl(isonicotinyl}piperidine-4-one)
|
|
IL302719B2
(en)
|
2018-02-28 |
2025-10-01 |
Basf Se |
Use of N–functional alkoxypyrazole compounds as nitrification inhibitors
|
|
WO2019166558A1
(en)
|
2018-02-28 |
2019-09-06 |
Basf Se |
Use of pyrazole propargyl ethers as nitrification inhibitors
|
|
SMT202400306T1
(it)
|
2018-03-30 |
2024-09-16 |
Incyte Corp |
Trattamento dell'idrosadenite suppurativa utilizzando inibitori di jak.
|
|
CN112469418A
(zh)
|
2018-06-01 |
2021-03-09 |
因赛特公司 |
治疗pi3k相关病症的给药方案
|
|
CN110885331B
(zh)
*
|
2018-09-11 |
2021-07-09 |
中国药科大学 |
一种6-氨基-1H-吡唑并[3，4-d]嘧啶类JAK激酶抑制剂的制备与应用
|
|
CA3112073A1
(en)
|
2018-10-11 |
2020-04-16 |
Basf As |
Aromatic compounds and pharmaceutical uses thereof
|
|
WO2020092015A1
(en)
|
2018-11-02 |
2020-05-07 |
University Of Rochester |
Therapeutic mitigation of epithelial infection
|
|
CN114269734A
(zh)
|
2019-05-08 |
2022-04-01 |
维玛兰生物科学公司 |
Jak抑制剂
|
|
MX2021014455A
(es)
*
|
2019-05-27 |
2022-01-06 |
Dizal Jiangsu Pharmaceutical Co Ltd |
Inhibidores de proteina cinasas dependientes de adn.
|
|
TW202122400A
(zh)
*
|
2019-08-08 |
2021-06-16 |
美商維瑪蘭生物科學公司 |
Jak抑制劑
|
|
ES3025474T3
(en)
*
|
2020-01-15 |
2025-06-09 |
Ksq Therapeutics Inc |
Compositions of substituted pyrazolopyrimidines and uses thereof
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
MX2023004937A
(es)
*
|
2020-10-30 |
2023-05-17 |
Ksq Therapeutics Inc |
Formas en estado solido de pirazolopirimidinas sustituidas y usos de estas.
|
|
US20240270658A1
(en)
|
2021-05-21 |
2024-08-15 |
Basf Se |
Use of an N-Functionalized Alkoxy Pyrazole Compound as Nitrification Inhibitor
|
|
WO2024238570A1
(en)
*
|
2023-05-15 |
2024-11-21 |
Aleksia Therapeutics, Inc. |
Cdk2 inhibitor pyrazolopyrimidine compounds
|